Properties
Description
Velagliflozin is a sodium-glucose cotransporter inhibitor, preventing the kidneys from reabsorbing glucose. It targets SGLT2.
Molecular Formula
C23H25NO5
Identity
Confirmed by NMR/HPLC/MS.
Applications
Velagliflozin is used to study the inhibition of sodium-glucose transporters, impacting glucose management in diabetes.